BRPI1014081A2 - uso de uma bactéria da espécie bifidobacterium animalis subsp lactis cepa 420 (b420) ou uma mistura da mesma - Google Patents

uso de uma bactéria da espécie bifidobacterium animalis subsp lactis cepa 420 (b420) ou uma mistura da mesma

Info

Publication number
BRPI1014081A2
BRPI1014081A2 BRPI1014081A BRPI1014081A BRPI1014081A2 BR PI1014081 A2 BRPI1014081 A2 BR PI1014081A2 BR PI1014081 A BRPI1014081 A BR PI1014081A BR PI1014081 A BRPI1014081 A BR PI1014081A BR PI1014081 A2 BRPI1014081 A2 BR PI1014081A2
Authority
BR
Brazil
Prior art keywords
bacterium
mixture
bifidobacterium animalis
lactis strain
animalis subsp
Prior art date
Application number
BRPI1014081A
Other languages
English (en)
Inventor
Didier Carcano
Remy Burcelin
Sampo Lahtinen
Original Assignee
Danisco
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Danisco filed Critical Danisco
Publication of BRPI1014081A2 publication Critical patent/BRPI1014081A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A23V2400/515—Animalis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
BRPI1014081A 2009-06-19 2010-06-18 uso de uma bactéria da espécie bifidobacterium animalis subsp lactis cepa 420 (b420) ou uma mistura da mesma BRPI1014081A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21856309P 2009-06-19 2009-06-19
PCT/IB2010/052757 WO2010146568A2 (en) 2009-06-19 2010-06-18 Bifidobacteria for treating diabetes and related conditions

Publications (1)

Publication Number Publication Date
BRPI1014081A2 true BRPI1014081A2 (pt) 2016-04-19

Family

ID=42989263

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1014081A BRPI1014081A2 (pt) 2009-06-19 2010-06-18 uso de uma bactéria da espécie bifidobacterium animalis subsp lactis cepa 420 (b420) ou uma mistura da mesma

Country Status (8)

Country Link
US (7) US20120107291A1 (pt)
EP (3) EP2442814B1 (pt)
CN (5) CN104770739A (pt)
BR (1) BRPI1014081A2 (pt)
DK (3) DK2808024T3 (pt)
ES (3) ES2702977T3 (pt)
PL (3) PL2442814T3 (pt)
WO (1) WO2010146568A2 (pt)

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102670661B (zh) * 2011-03-08 2013-10-02 惠宏襄 用于刺激胰高血糖素样肽-1分泌的药物
ITMI20111488A1 (it) 2011-08-03 2013-02-04 Gnosis Spa Formulazioni comprendenti saccharomyces boulardii e superossido dismutasi (sod) per controllare l'obesita'
CN103082292B (zh) * 2011-11-02 2015-03-04 深圳华大基因研究院 罗斯氏菌(Roseburia)在治疗和预防肥胖相关疾病中的应用
WO2013130773A2 (en) 2012-02-29 2013-09-06 Ethicon Endo-Surgery, Inc. Compositions of microbiota and methods related thereto
CN102792919B (zh) 2012-08-08 2015-09-09 上海交通大学 悉生动物肥胖模型的构建方法及其应用
NO2895012T3 (pt) * 2012-09-11 2018-03-17
ES2770401T3 (es) * 2012-09-20 2020-07-01 Prothera Inc Composiciones probióticas para el tratamiento de la obesidad y afecciones relacionadas con la obesidad
RU2015129066A (ru) * 2012-12-20 2017-01-23 Компани Жервэ Данон Применение bifidobacterium animalis для лечения или предотвращения набора веса и инсулинорезистентности
ES2526986B1 (es) 2013-07-18 2015-11-02 Biopolis, S.L. Nueva cepa de Bifidobacterium animalis subsp. lactis CECT 8145 y su uso para el tratamiento y/o prevención de sobrepeso y obesidad y enfermedades asociadas
WO2015013214A2 (en) 2013-07-21 2015-01-29 Whole Biome, Inc. Methods and systems for microbiome characterization, monitoring and treatment
CA2926466C (en) * 2013-10-03 2021-11-16 Frederic Bushman Compositions comprising a defined microbiome and methods of use thereof
US10058576B2 (en) 2013-10-03 2018-08-28 The Trustees Of The University Of Pennsylvania Compositions and methods comprising a defined microbiome and methods of use thereof
CA2938790A1 (fr) * 2014-02-14 2015-08-20 Vesale Pharma Sa Composition comprenant du bifidobacterium animalis ssp. lactis
WO2015121455A1 (fr) * 2014-02-14 2015-08-20 Vesale Pharma Sa Composition comprenant au moins un probiotique
WO2015121458A2 (fr) * 2014-02-14 2015-08-20 Vesale Pharma Sa Composition comprenant du bifidobacterium animalis ssp. lactis
BE1000016B1 (fr) * 2014-04-25 2016-02-01 Vesale Pharma Nv Composition comprenant du bifidobacterium animalis ssp. lactis.
BE1000017B1 (fr) * 2014-04-25 2016-01-21 Vesale Pharma Nv Composition comprenant au moins un probiotique
WO2016020485A1 (en) * 2014-08-08 2016-02-11 Nestec S.A. A combination of vitamin d and zinc and its use
WO2016020486A1 (en) * 2014-08-08 2016-02-11 Nestec S.A. A combination of myo-inositol and zinc and its use
EP3881680A1 (en) 2014-10-31 2021-09-22 Pendulum Therapeutics, Inc. Methods and compositions relating to microbial treatment
TWI572713B (zh) * 2014-10-31 2017-03-01 豐華生物科技股份有限公司 抗肥胖之乳酸菌菌株及其於食品組成物以及醫藥組成物之應用
KR20170128247A (ko) * 2015-01-23 2017-11-22 템플 유니버시티-오브 더 커먼웰쓰 시스템 오브 하이어 에듀케이션 암 예방에서 단쇄 지방산의 용도
GB201514303D0 (en) * 2015-07-16 2015-09-23 Dupont Nutrition Biosci Aps Bifidobacteria for treating cardiac conditions
GB201514302D0 (en) * 2015-07-16 2015-09-23 Dupont Nutrition Biosci Aps Lactobacilli for treating cardiac dysfunction
US9980491B2 (en) * 2015-07-25 2018-05-29 Siobhan Reilly Probiotic compositions and methods of use
EP3173085A1 (en) * 2015-11-30 2017-05-31 Vaiomer Polydextrose for the prevention and/or treatment of heart failure
CN105770892A (zh) * 2016-02-04 2016-07-20 烟台金海药业有限公司 一种防治鸡心包积液-肝炎综合征生物兽药的制备方法
CN105797156A (zh) * 2016-03-15 2016-07-27 烟台金海药业有限公司 一种防治hhs的抗原抗体复合物制剂的制备方法
CN107224584A (zh) * 2016-03-25 2017-10-03 上海来益生物药物研究开发中心有限责任公司 一种益生菌组合物及其应用
CA3020365A1 (en) * 2016-04-14 2017-10-19 Dupont Nutrition Biosciences Aps Bifidobacteria for reducing food, energy and/or fat intake
BR112018070512A2 (pt) * 2016-04-14 2019-01-29 Dupont Nutrition Biosci Aps composição, usos de uma composição e método para aumentar a massa corporal magra
JP6986856B2 (ja) * 2016-05-10 2021-12-22 協同乳業株式会社 トリメチルアミンを産生し難い腸内菌叢を形成するためのプロバイオティクス組成物および方法
CN106619742A (zh) * 2016-11-08 2017-05-10 江西益盟科技有限公司 治疗糖尿病的乳酸菌组合物及其制备方法
WO2018104263A1 (en) * 2016-12-06 2018-06-14 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods of enhancing the potency of incretin-based drugs in subjects in need thereof
MX2019009079A (es) * 2017-01-31 2019-09-26 Univ Industry Cooperation Group Kyung Hee Univ Nuevas bacterias acido lacticas y usos de las mismas.
KR20190116248A (ko) * 2017-02-10 2019-10-14 퍼펙트 (차이나) 씨오., 엘티디 신규한 프로바이오틱스 비피도박테리움 균주
CN106617096B (zh) * 2017-02-15 2020-12-18 中国农业大学 一种增强胰岛功能的双歧杆菌及其应用
CN107050065B (zh) * 2017-03-31 2021-03-30 杭州远大生物制药有限公司 双歧四联活菌组合物的新应用
CN107410486A (zh) * 2017-06-27 2017-12-01 合肥工业大学 一种降血糖玫瑰茄发酵乳的制备方法
WO2019002609A1 (en) * 2017-06-30 2019-01-03 N.V. Nutricia SYMBIOTIC COMPOSITION FOR THE PREVENTION OF METABOLIC DISORDERS
JP2020530011A (ja) * 2017-08-06 2020-10-15 セカンド ゲノム インコーポレイテッド バイオ治療薬としてのストレプトコッカス・オーストラリス（Ｓｔｒｅｐｔｏｃｏｃｃｕｓ ａｕｓｔｒａｌｉｓ）
EP3675882A4 (en) 2017-08-30 2021-07-28 Pendulum Therapeutics, Inc. METHODS AND COMPOSITIONS FOR THE TREATMENT OF MICROBIOMA ASSOCIATED DISORDERS
CN107723257A (zh) * 2017-09-20 2018-02-23 深圳市晨光乳业有限公司 一种动物双歧杆菌及其食品组合物
WO2019067087A1 (en) * 2017-09-26 2019-04-04 Second Genome, Inc. GEMELLA SANGUINIS AS BIOTHERAPEUTIC AGENTS
US20200261516A1 (en) * 2017-10-31 2020-08-20 Morinaga Milk Industry Co., Ltd. Composition for Increasing Muscle Mass
US20200345795A1 (en) * 2017-11-01 2020-11-05 Medlab Ip Pty Ltd Modulation of intestinal microbiota in pre-diabetes and type 2 diabetes
WO2019092021A1 (en) * 2017-11-09 2019-05-16 Nestec S.A. An array of age-tailored nutritional formula for infants and young children for use in the prevention of sub-optimal body composition
EP3777868A4 (en) * 2018-03-23 2021-12-01 Morinaga Milk Industry Co., Ltd. COMPOSITION FOR INFANTS INTENDED TO PREVENT DISEASES CAUSED BY HYPERGLYCEMIA FROM SCHOOL AGE
CN109259243A (zh) * 2018-09-26 2019-01-25 广州普维君健药业有限公司 降三高的组合物及其制备方法和应用
US20220031770A1 (en) * 2018-12-07 2022-02-03 Bgi Shenzhen Use of Megamonas funiformis in preventing and/or treating metabolic diseases
CN109486715B (zh) * 2018-12-07 2022-07-15 江苏靶标生物医药研究所有限公司 一种富硒长双歧杆菌及其制备方法和应用
CN109998113A (zh) * 2019-04-18 2019-07-12 广东省微生物研究所（广东省微生物分析检测中心） 一种具有降血糖功效的益生菌制剂的功能性食品
CN110150669B (zh) * 2019-04-29 2022-09-06 河北一然生物科技股份有限公司 一种适于糖尿病患者食用的益生菌组合物及其应用
CN114667153A (zh) * 2019-05-30 2022-06-24 科克大学 产生gaba的可培养细菌和用于改善健康的用途
CN110604749B (zh) * 2019-08-30 2020-08-14 北京农学院 动物双歧杆菌a12及其在控制糖尿病或高血脂症特别是体重增加或肥胖中的应用
EP4040984A4 (en) 2019-09-25 2024-01-17 Tall Goods Llc METHOD FOR PRODUCING PROBIOTICALLY ENHANCED BIRD EGGS AND EGG PRODUCTS AND FORMULATIONS THEREOF
CN113197313B (zh) * 2020-09-02 2023-10-27 内蒙古蒙牛乳业（集团）股份有限公司 具有改善胰岛素抵抗及空腹血糖的益生菌组合物及制备方法
WO2022049433A1 (en) 2020-09-04 2022-03-10 Societe Des Produits Nestle Sa Compositions and methods for providing health benefits in an animal
CN113207961B (zh) * 2020-09-29 2023-06-23 内蒙古蒙牛乳业（集团）股份有限公司 乳双歧杆菌MN-Gup乳制品及其在改善2型糖尿病中应用
CN112535275A (zh) * 2020-12-10 2021-03-23 淮北师范大学 一种具有α-葡萄糖苷酶抑制活性的发酵菊花凉拌酱的制备方法
CN113215030B (zh) * 2021-04-12 2022-10-25 天津中医药大学 约氏乳杆菌eu03及其用途
CN113249264B (zh) * 2021-06-03 2021-11-23 北京量化健康科技有限公司 一株青春双歧杆菌及其在代谢综合征中的应用
CN113678979A (zh) * 2021-08-25 2021-11-23 上海英库商务咨询有限公司 用于促使ii型糖尿病人群胰岛素合成和分泌的固体饮料
CN113995720B (zh) * 2021-11-15 2023-03-17 郑州大学 一种乳剂包被型益生菌制剂及其制备方法与应用
CN115466689B (zh) * 2022-02-09 2023-06-16 中国科学技术大学 用于预防和/或治疗代谢类疾病的益生菌组合物及其应用
CN115281345A (zh) * 2022-04-06 2022-11-04 金华银河生物科技有限公司 一种复合益生菌组合物联合二甲基胍治疗ⅱ型糖尿病的用途
WO2023219460A1 (ko) * 2022-05-12 2023-11-16 주식회사 지아이바이옴 락토바실러스 퍼멘텀 균주 및 대사조절제를 포함하는 병용 요법을 이용한 대사질환 예방 또는 치료용 조성물
CN115948273B (zh) * 2022-06-21 2023-07-18 合肥瀚微生物科技有限公司 治疗糖尿病及相关病症的两歧双歧杆菌
CN115137757A (zh) * 2022-07-29 2022-10-04 承葛健康科技(广东)有限公司 一种辅助降血糖的益生菌组合物
CN117187145A (zh) * 2023-10-20 2023-12-08 深圳保时健生物工程有限公司 一株具有降脂、降血糖和减重功能的嗜酸乳杆菌goldgut-la100及其应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2002003A (en) 1930-09-20 1935-05-21 Ig Farbenindustrie Ag Production of acetylene and carbon black
JP2779963B2 (ja) * 1989-02-09 1998-07-23 株式会社林原生物化学研究所 ビフィズス菌増殖促進剤
SE510753C2 (sv) * 1997-08-05 1999-06-21 Probi Ab Användning av en stam av Lactobacillus för tillverkning av ett läkemedel för reduktion av fibrinogenhalten i blod
US6811786B1 (en) * 1999-04-01 2004-11-02 Ganeden Biotech, Inc. Methods for reducing cholesterol using Bacillus coagulans spores, systems and compositions
JP4580542B2 (ja) * 2000-05-17 2010-11-17 株式會社バイオニア 肥満又は糖尿病治療用微生物及びその微生物を含む医薬組成物
SE0004124D0 (sv) 2000-11-10 2000-11-10 Probi Ab New use
PE20030284A1 (es) * 2001-07-26 2003-05-01 Alimentary Health Ltd Cepas de bifidobacterium
US6953574B2 (en) * 2002-06-21 2005-10-11 Technology Commercialization, Inc. Method for producing a fermented hydrolyzed medium containing microorganisms
KR100527103B1 (ko) * 2003-02-04 2005-11-09 최현우 지질대사개선효능을 갖는 미생물을 함유한 성인병 예방 및치료용 조성물 및 이의 용도
ES2702631T5 (es) * 2005-02-28 2023-03-22 Nutricia Nv Composición nutricional con prebióticos y probióticos
SE529185C2 (sv) * 2005-10-07 2007-05-22 Arla Foods Amba Användning av probiotiska bakterier för tillverkning av livsmedel eller läkemedel för förhindrande av övervikt
PL1983849T3 (pl) * 2006-01-20 2013-09-30 Innova Food Ab Kompozycja spożywcza zawierająca aminokwasy
KR101108428B1 (ko) 2006-08-04 2012-01-31 (주)바이오니아 인간의 모유에서 분리한 프로바이오틱 활성 및 체중 증가억제 효과를 갖는 유산균
CN101310606A (zh) * 2007-05-24 2008-11-26 大连森佰澳科技有限公司 含有双歧杆菌功能信号分子和益生元的液体奶制品
EP2011506A1 (en) 2007-07-05 2009-01-07 Nestec S.A. Supplementation of maternal diet
EP2022502A1 (en) 2007-08-10 2009-02-11 Nestec S.A. Lactobacillus rhamnosus and weight control
EP2030623A1 (en) 2007-08-17 2009-03-04 Nestec S.A. Preventing and/or treating metabolic disorders by modulating the amount of enterobacteria
US20110189149A1 (en) * 2008-06-20 2011-08-04 Remy Burcelin New Uses of Lactic Acid Bacteria and Bifidobacteria

Also Published As

Publication number Publication date
ES2763137T3 (es) 2020-05-27
CN102458415B (zh) 2015-05-20
CN102458415A (zh) 2012-05-16
EP3181134B1 (en) 2019-10-30
CN104784694A (zh) 2015-07-22
US20120107291A1 (en) 2012-05-03
PL3181134T3 (pl) 2020-04-30
US20210322491A1 (en) 2021-10-21
US20180021391A1 (en) 2018-01-25
EP2442814B1 (en) 2018-09-26
CN104784220A (zh) 2015-07-22
DK2808024T3 (da) 2019-06-11
ES2729765T3 (es) 2019-11-06
US20190307815A1 (en) 2019-10-10
DK2442814T3 (en) 2019-01-14
EP2442814A2 (en) 2012-04-25
EP2808024B1 (en) 2019-04-24
ES2702977T3 (es) 2019-03-06
EP2808024A1 (en) 2014-12-03
US20200316144A1 (en) 2020-10-08
EP3181134A1 (en) 2017-06-21
US20140348796A1 (en) 2014-11-27
US20230248786A1 (en) 2023-08-10
PL2808024T3 (pl) 2019-09-30
CN104770739A (zh) 2015-07-15
WO2010146568A2 (en) 2010-12-23
WO2010146568A3 (en) 2011-05-05
DK3181134T3 (da) 2020-01-20
PL2442814T3 (pl) 2019-04-30
CN104784219A (zh) 2015-07-22

Similar Documents

Publication Publication Date Title
BRPI1014081A2 (pt) uso de uma bactéria da espécie bifidobacterium animalis subsp lactis cepa 420 (b420) ou uma mistura da mesma
HK1226100B (zh) 雙歧桿菌乳酸亞種(bifidobacterium animalis subsp．lactis)cect 8145的新菌株及其用於治療和/或預防超重和肥胖症以及相關疾病的用途
DK2318513T3 (da) Ny probiotisk bifidobacterium longum
GB2460781B (en) Probiotic bifidobacterium strains
GB2465051B (en) Probiotic bifidobacterium strains
ATE537707T1 (de) Lactobacillus paracasei und gewichtskontrolle
DK2657333T3 (da) Porcint circovirus type 2, immunsammensætning indeholdende samme, assaykit og anvendelse deraf
DE602006010723D1 (de) Neues bakterium der gattung bifidobacterium und dessen nutzung
CL2012003026A1 (es) Composicion farmaceutica que comprende pioglitazona y linagliptina; procedimiento de preparacion; uso en el tratamiento de la diabetes tipo 2 o la obesidad.
DK1824500T3 (da) Probiotisk lactobacillus-stamme til forbedret vaginal sundhed
BRPI1014304A2 (pt) bifidobacterium longum ncc2705 (cncm i-2618) e distúrbios imunes
WO2009112361A3 (en) Synbiotic mixture
IL205398A0 (en) New antibodies specific of the ?? - amyloid peptides and their uses as diagnostic agents or drugs
BRPI0817905A2 (pt) Utilização de uma cepa de bifidobacterium, para o preparo de uma composição destinada à prevenção e/ou ao tratamento de manifestações do tipo alérgicas
EP2576587A4 (en) MUTANT NGAL PROTEINS AND USES THEREOF
DK2802333T3 (da) Lactobacillus rhamnosus og Bifidobacterium animalis subsp. lactis til anvendelse til forebyggelse eller behandling af øvre luftvejsinfektioner
ATE421572T1 (de) Neue stämme von lactobacillus helveticus
BRPI0913297A2 (pt) composição, farmacêutica, uso de uma composição, e, kit terapêutico.
ATE530070T1 (de) Verwendung von lactobacillus casei zur verstärkung der schutzwirkung der grippeimpfung
BR112014002911A2 (pt) linhagem de l. bulgaricus capaz de inibir a adesão de linhagens de h. pylori a células epiteliais
ATE423840T1 (de) Neue stämme von lactobacillus helveticus
IL210068A0 (en) Compositions and methods of use of orf 554 from beta hemolytic streptococcal strains
AP2008004650A0 (en) Novel enterococcus and streptococcus strains and bacteriocins
BRPI0909760A2 (pt) Cepa de lactobacillus rhamnosus
PL384006A1 (pl) Nowy szczep bakterii Lactobacillus casei C8/4

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B25D Requested change of name of applicant approved

Owner name: DUPONT NUTRITION BIOSCIENCES APS (DK)

B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]